APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Transdermal Medical Patch

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Transdermal Medical Patch Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 17404258032 January 2026191 pages

Choose your research edition.

Industry ResearchTransdermal Medical Patch Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Transdermal Medical Patch Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Transdermal Medical Patch Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Transdermal Medical Patch Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Transdermal Medical Patch Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Transdermal Medical Patch market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Transdermal Medical Patch is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Transdermal Medical Patch is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Transdermal Medical Patch is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Transdermal Medical Patch is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Transdermal Medical Patch include Teva Pharmaceutical, Johnson & Johnson, Novartis, Mylan, Pfizer, GSK, Beijing Tide Pharmaceutical, Bayer and UCB Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Transdermal Medical Patch market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Transdermal Medical Patch and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Transdermal Medical Patch sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Transdermal Medical Patch market size, projected growth trends, production technologies, key applications, and end-use industries.

Transdermal Medical Patch Segment by Company

Teva Pharmaceutical

Johnson & Johnson

Novartis

Mylan

Pfizer

GSK

Beijing Tide Pharmaceutical

Bayer

UCB Pharma

Nitto Denko

Mundipharma

Luye Pharma Group

IBSA Group

Hisamitsu Pharmaceutical

Grünenthal

Endo International

Dr Reddy’s Laboratories

Chattem

Transdermal Medical Patch Segment by Type

Fentanyl Patch

Lidocaine Patch

Rivastigmine Patch

Nicotine Patch

Diclofenac Patch

Methyl Salicylate-Based Patch

Others

Transdermal Medical Patch Segment by Application

Offline Channel

Online Channel

Transdermal Medical Patch Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Medical Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transdermal Medical Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Medical Patch.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Transdermal Medical Patch market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Transdermal Medical Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Transdermal Medical Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Transdermal Medical Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Transdermal Medical Patch Industry Trends Table 2. Transdermal Medical Patch Industry Drivers Table 3. Transdermal Medical Patch Industry Opportunities and Challenges Table 4. Transdermal Medical Patch Industry Restraints Table 5. Global Transdermal Medical Patch Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Transdermal Medical Patch Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Transdermal Medical Patch Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Transdermal Medical Patch Sales Market Share by Manufacturers Table 9. Global Transdermal Medical Patch Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Transdermal Medical Patch Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Transdermal Medical Patch Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Transdermal Medical Patch Manufacturers, Product Type & Application Table 13. Global Transdermal Medical Patch Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Transdermal Medical Patch by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Fentanyl Patch Table 17. Major Manufacturers of Lidocaine Patch Table 18. Major Manufacturers of Rivastigmine Patch Table 19. Major Manufacturers of Nicotine Patch Table 20. Major Manufacturers of Diclofenac Patch Table 21. Major Manufacturers of Methyl Salicylate-Based Patch Table 22. Major Manufacturers of Others Table 23. Global Transdermal Medical Patch Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Transdermal Medical Patch Sales by Type (2021-2026) & (K Units) Table 25. Global Transdermal Medical Patch Sales by Type (2027-2032) & (K Units) Table 26. Global Transdermal Medical Patch Sales Market Share by Type (2021-2026) Table 27. Global Transdermal Medical Patch Sales Market Share by Type (2027-2032) Table 28. Global Transdermal Medical Patch Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 29. Global Transdermal Medical Patch Revenue by Type (2021-2026) & (K Units) Table 30. Global Transdermal Medical Patch Revenue by Type (2027-2032) & (K Units) Table 31. Global Transdermal Medical Patch Revenue Market Share by Type (2021-2026) Table 32. Global Transdermal Medical Patch Revenue Market Share by Type (2027-2032) Table 33. Major Manufacturers of Offline Channel Table 34. Major Manufacturers of Online Channel Table 35. Global Transdermal Medical Patch Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Transdermal Medical Patch Sales by Application (2021-2026) & (K Units) Table 37. Global Transdermal Medical Patch Sales by Application (2027-2032) & (K Units) Table 38. Global Transdermal Medical Patch Sales Market Share by Application (2021-2026) Table 39. Global Transdermal Medical Patch Sales Market Share by Application (2027-2032) Table 40. Global Transdermal Medical Patch Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 41. Global Transdermal Medical Patch Revenue by Application (2021-2026) & (K Units) Table 42. Global Transdermal Medical Patch Revenue by Application (2027-2032) & (K Units) Table 43. Global Transdermal Medical Patch Revenue Market Share by Application (2021-2026) Table 44. Global Transdermal Medical Patch Revenue Market Share by Application (2027-2032) Table 45. Global Transdermal Medical Patch Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Transdermal Medical Patch Sales by Region (2021-2026) & (K Units) Table 47. Global Transdermal Medical Patch Sales Market Share by Region (2021-2026) Table 48. Global Transdermal Medical Patch Sales Forecasted by Region (2027-2032) & (K Units) Table 49. Global Transdermal Medical Patch Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Transdermal Medical Patch Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. North America Transdermal Medical Patch Sales by Country (2021-2026) & (K Units) Table 52. North America Transdermal Medical Patch Sales by Country (2027-2032) & (K Units) Table 53. Europe Transdermal Medical Patch Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Europe Transdermal Medical Patch Sales by Country (2021-2026) & (K Units) Table 55. Europe Transdermal Medical Patch Sales by Country (2027-2032) & (K Units) Table 56. Asia Pacific Transdermal Medical Patch Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Asia Pacific Transdermal Medical Patch Sales by Country (2021-2026) & (K Units) Table 58. Asia Pacific Transdermal Medical Patch Sales by Country (2027-2032) & (K Units) Table 59. South America, Middle East and Africa Transdermal Medical Patch Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 60. South America, Middle East and Africa Transdermal Medical Patch Sales by Country (2021-2026) & (K Units) Table 61. South America, Middle East and Africa Transdermal Medical Patch Sales by Country (2027-2032) & (K Units) Table 62. Global Transdermal Medical Patch Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Transdermal Medical Patch Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Transdermal Medical Patch Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Transdermal Medical Patch Revenue Market Share by Region (2021-2026) Table 66. Global Transdermal Medical Patch Revenue Market Share by Region (2027-2032) Table 67. Teva Pharmaceutical Company Information Table 68. Teva Pharmaceutical Business Overview Table 69. Teva Pharmaceutical Transdermal Medical Patch Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Teva Pharmaceutical Transdermal Medical Patch Product Portfolio Table 71. Teva Pharmaceutical Recent Development Table 72. Johnson & Johnson Company Information Table 73. Johnson & Johnson Business Overview Table 74. Johnson & Johnson Transdermal Medical Patch Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Johnson & Johnson Transdermal Medical Patch Product Portfolio Table 76. Johnson & Johnson Recent Development Table 77. Novartis Company Information Table 78. Novartis Business Overview Table 79. Novartis Transdermal Medical Patch Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Novartis Transdermal Medical Patch Product Portfolio Table 81. Novartis Recent Development Table 82. Mylan Company Information Table 83. Mylan Business Overview Table 84. Mylan Transdermal Medical Patch Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Mylan Transdermal Medical Patch Product Portfolio Table 86. Mylan Recent Development Table 87. Pfizer Company Information Table 88. Pfizer Business Overview Table 89. Pfizer Transdermal Medical Patch Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Pfizer Transdermal Medical Patch Product Portfolio Table 91. Pfizer Recent Development Table 92. GSK Company Information Table 93. GSK Business Overview Table 94. GSK Transdermal Medical Patch Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. GSK Transdermal Medical Patch Product Portfolio Table 96. GSK Recent Development Table 97. Beijing Tide Pharmaceutical Company Information Table 98. Beijing Tide Pharmaceutical Business Overview Table 99. Beijing Tide Pharmaceutical Transdermal Medical Patch Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Beijing Tide Pharmaceutical Transdermal Medical Patch Product Portfolio Table 101. Beijing Tide Pharmaceutical Recent Development Table 102. Bayer Company Information Table 103. Bayer Business Overview Table 104. Bayer Transdermal Medical Patch Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Bayer Transdermal Medical Patch Product Portfolio Table 106. Bayer Recent Development Table 107. UCB Pharma Company Information Table 108. UCB Pharma Business Overview Table 109. UCB Pharma Transdermal Medical Patch Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. UCB Pharma Transdermal Medical Patch Product Portfolio Table 111. UCB Pharma Recent Development Table 112. Nitto Denko Company Information Table 113. Nitto Denko Business Overview Table 114. Nitto Denko Transdermal Medical Patch Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Nitto Denko Transdermal Medical Patch Product Portfolio Table 116. Nitto Denko Recent Development Table 117. Mundipharma Company Information Table 118. Mundipharma Business Overview Table 119. Mundipharma Transdermal Medical Patch Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Mundipharma Transdermal Medical Patch Product Portfolio Table 121. Mundipharma Recent Development Table 122. Luye Pharma Group Company Information Table 123. Luye Pharma Group Business Overview Table 124. Luye Pharma Group Transdermal Medical Patch Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Luye Pharma Group Transdermal Medical Patch Product Portfolio Table 126. Luye Pharma Group Recent Development Table 127. IBSA Group Company Information Table 128. IBSA Group Business Overview Table 129. IBSA Group Transdermal Medical Patch Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. IBSA Group Transdermal Medical Patch Product Portfolio Table 131. IBSA Group Recent Development Table 132. Hisamitsu Pharmaceutical Company Information Table 133. Hisamitsu Pharmaceutical Business Overview Table 134. Hisamitsu Pharmaceutical Transdermal Medical Patch Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. Hisamitsu Pharmaceutical Transdermal Medical Patch Product Portfolio Table 136. Hisamitsu Pharmaceutical Recent Development Table 137. Grünenthal Company Information Table 138. Grünenthal Business Overview Table 139. Grünenthal Transdermal Medical Patch Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. Grünenthal Transdermal Medical Patch Product Portfolio Table 141. Grünenthal Recent Development Table 142. Endo International Company Information Table 143. Endo International Business Overview Table 144. Endo International Transdermal Medical Patch Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 145. Endo International Transdermal Medical Patch Product Portfolio Table 146. Endo International Recent Development Table 147. Dr Reddy’s Laboratories Company Information Table 148. Dr Reddy’s Laboratories Business Overview Table 149. Dr Reddy’s Laboratories Transdermal Medical Patch Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 150. Dr Reddy’s Laboratories Transdermal Medical Patch Product Portfolio Table 151. Dr Reddy’s Laboratories Recent Development Table 152. Chattem Company Information Table 153. Chattem Business Overview Table 154. Chattem Transdermal Medical Patch Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 155. Chattem Transdermal Medical Patch Product Portfolio Table 156. Chattem Recent Development Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Transdermal Medical Patch Distributors List Table 160. Transdermal Medical Patch Customers List Table 161. Research Programs/Design for This Report Table 162. Authors List of This Report Table 163. Secondary Sources Table 164. Primary Sources List of Figures Figure 1. Transdermal Medical Patch Product Image Figure 2. Global Transdermal Medical Patch Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Transdermal Medical Patch Market Size (2021-2032) & (US$ Million) Figure 4. Global Transdermal Medical Patch Sales (2021-2032) & (K Units) Figure 5. Global Transdermal Medical Patch Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Transdermal Medical Patch Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Fentanyl Patch Image Figure 9. Lidocaine Patch Image Figure 10. Rivastigmine Patch Image Figure 11. Nicotine Patch Image Figure 12. Diclofenac Patch Image Figure 13. Methyl Salicylate-Based Patch Image Figure 14. Others Image Figure 15. Global Transdermal Medical Patch Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Transdermal Medical Patch Sales Market Share 2021 VS 2025 VS 2032 Figure 17. Global Transdermal Medical Patch Sales Market Share by Type (2021-2032) Figure 18. Global Transdermal Medical Patch Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Transdermal Medical Patch Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Transdermal Medical Patch Revenue Market Share by Type (2021-2032) Figure 21. Offline Channel Image Figure 22. Online Channel Image Figure 23. Global Transdermal Medical Patch Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Transdermal Medical Patch Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Transdermal Medical Patch Sales Market Share by Application (2021-2032) Figure 26. Global Transdermal Medical Patch Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 27. Global Transdermal Medical Patch Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Transdermal Medical Patch Revenue Market Share by Application (2021-2032) Figure 29. North America Transdermal Medical Patch Sales and Growth Rate (2021-2032) & (K Units) Figure 30. North America Transdermal Medical Patch Sales Market Share by Country (2021-2032) Figure 31. U.S. Transdermal Medical Patch Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Canada Transdermal Medical Patch Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Mexico Transdermal Medical Patch Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Transdermal Medical Patch Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe Transdermal Medical Patch Sales Market Share by Country (2021-2032) Figure 36. Germany Transdermal Medical Patch Sales and Growth Rate (2021-2032) & (K Units) Figure 37. France Transdermal Medical Patch Sales and Growth Rate (2021-2032) & (K Units) Figure 38. U.K. Transdermal Medical Patch Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Italy Transdermal Medical Patch Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Netherlands Transdermal Medical Patch Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Transdermal Medical Patch Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific Transdermal Medical Patch Sales Market Share by Country (2021-2032) Figure 43. China Transdermal Medical Patch Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Japan Transdermal Medical Patch Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South Korea Transdermal Medical Patch Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Southeast Asia Transdermal Medical Patch Sales and Growth Rate (2021-2032) & (K Units) Figure 47. India Transdermal Medical Patch Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Australia Transdermal Medical Patch Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Transdermal Medical Patch Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa Transdermal Medical Patch Sales Market Share by Country (2021-2032) Figure 51. Brazil Transdermal Medical Patch Sales and Growth Rate (2021-2032) & (K Units) Figure 52. South Africa Transdermal Medical Patch Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Saudi Arabia Transdermal Medical Patch Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Turkey Transdermal Medical Patch Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Argentina Transdermal Medical Patch Sales and Growth Rate (2021-2032) & (K Units) Figure 56. UAE Transdermal Medical Patch Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Egypt Transdermal Medical Patch Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Chile Transdermal Medical Patch Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Global Transdermal Medical Patch Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Transdermal Medical Patch Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Transdermal Medical Patch Revenue (2021-2032) & (US$ Million) Figure 62. North America Transdermal Medical Patch Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Transdermal Medical Patch Revenue (2021-2032) & (US$ Million) Figure 64. Europe Transdermal Medical Patch Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Transdermal Medical Patch Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Transdermal Medical Patch Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Transdermal Medical Patch Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Transdermal Medical Patch Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Transdermal Medical Patch Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Transdermal Medical Patch Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Fentanyl Patch
  • Lidocaine Patch
  • Rivastigmine Patch
  • Nicotine Patch
  • Diclofenac Patch
  • Methyl Salicylate-Based Patch
  • Others
Applications
  • Offline Channel
  • Online Channel
Companies covered
  • Teva Pharmaceutical
  • Johnson & Johnson
  • Novartis
  • Mylan
  • Pfizer
  • GSK
  • Beijing Tide Pharmaceutical
  • Bayer
  • UCB Pharma
  • Nitto Denko
  • Mundipharma
  • Luye Pharma Group
  • IBSA Group
  • Hisamitsu Pharmaceutical
  • Grünenthal
  • Endo International
  • Dr Reddy’s Laboratories
  • Chattem

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Transdermal Medical Patch Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Transdermal Medical Patch Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Transdermal Medical Patch Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Transdermal Medical Patch Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Transdermal Medical Patch Market Dynamics
  1. 2.1 Transdermal Medical Patch Industry Trends
  2. 2.2 Transdermal Medical Patch Industry Drivers
  3. 2.3 Transdermal Medical Patch Industry Opportunities and Challenges
  4. 2.4 Transdermal Medical Patch Industry Restraints
3 Transdermal Medical Patch Market by Manufacturers
  1. 3.1 Global Transdermal Medical Patch Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Transdermal Medical Patch Sales by Manufacturers (2021-2026)
  3. 3.3 Global Transdermal Medical Patch Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Transdermal Medical Patch Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Transdermal Medical Patch Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Transdermal Medical Patch Manufacturers, Product Type & Application
  7. 3.7 Global Transdermal Medical Patch Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Transdermal Medical Patch Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Transdermal Medical Patch Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Transdermal Medical Patch Tier 1, Tier 2, and Tier 3
4 Transdermal Medical Patch Market by Type
  1. 4.1 Transdermal Medical Patch Type Introduction
  2. 4.1.1 Fentanyl Patch
  3. 4.1.2 Lidocaine Patch
  4. 4.1.3 Rivastigmine Patch
  5. 4.1.4 Nicotine Patch
  6. 4.1.5 Diclofenac Patch
  7. 4.1.6 Methyl Salicylate-Based Patch
  8. 4.1.7 Others
  9. 4.2 Global Transdermal Medical Patch Sales by Type
  10. 4.2.1 Global Transdermal Medical Patch Sales by Type (2021 VS 2025 VS 2032)
  11. 4.2.2 Global Transdermal Medical Patch Sales by Type (2021-2032)
  12. 4.2.3 Global Transdermal Medical Patch Sales Market Share by Type (2021-2032)
  13. 4.3 Global Transdermal Medical Patch Revenue by Type
  14. 4.3.1 Global Transdermal Medical Patch Revenue by Type (2021 VS 2025 VS 2032)
  15. 4.3.2 Global Transdermal Medical Patch Revenue by Type (2021-2032)
  16. 4.3.3 Global Transdermal Medical Patch Revenue Market Share by Type (2021-2032)
5 Transdermal Medical Patch Market by Application
  1. 5.1 Transdermal Medical Patch Application Introduction
  2. 5.1.1 Offline Channel
  3. 5.1.2 Online Channel
  4. 5.2 Global Transdermal Medical Patch Sales by Application
  5. 5.2.1 Global Transdermal Medical Patch Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Transdermal Medical Patch Sales by Application (2021-2032)
  7. 5.2.3 Global Transdermal Medical Patch Sales Market Share by Application (2021-2032)
  8. 5.3 Global Transdermal Medical Patch Revenue by Application
  9. 5.3.1 Global Transdermal Medical Patch Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Transdermal Medical Patch Revenue by Application (2021-2032)
  11. 5.3.3 Global Transdermal Medical Patch Revenue Market Share by Application (2021-2032)
6 Global Transdermal Medical Patch Sales by Region
  1. 6.1 Global Transdermal Medical Patch Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Transdermal Medical Patch Sales by Region (2021-2032)
  3. 6.2.1 Global Transdermal Medical Patch Sales by Region (2021-2026)
  4. 6.2.2 Global Transdermal Medical Patch Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Transdermal Medical Patch Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Transdermal Medical Patch Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Transdermal Medical Patch Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Transdermal Medical Patch Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Transdermal Medical Patch Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Transdermal Medical Patch Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Transdermal Medical Patch Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Transdermal Medical Patch Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Transdermal Medical Patch Revenue by Region
  1. 7.1 Global Transdermal Medical Patch Revenue by Region
  2. 7.1.1 Global Transdermal Medical Patch Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Transdermal Medical Patch Revenue by Region (2021-2026)
  4. 7.1.3 Global Transdermal Medical Patch Revenue by Region (2027-2032)
  5. 7.1.4 Global Transdermal Medical Patch Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Transdermal Medical Patch Revenue (2021-2032)
  8. 7.2.2 North America Transdermal Medical Patch Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Transdermal Medical Patch Revenue (2021-2032)
  11. 7.3.2 Europe Transdermal Medical Patch Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Transdermal Medical Patch Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Transdermal Medical Patch Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Transdermal Medical Patch Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Transdermal Medical Patch Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceutical
  2. 8.1.1 Teva Pharmaceutical Company Information
  3. 8.1.2 Teva Pharmaceutical Business Overview
  4. 8.1.3 Teva Pharmaceutical Transdermal Medical Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceutical Transdermal Medical Patch Product Portfolio
  6. 8.1.5 Teva Pharmaceutical Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Transdermal Medical Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Transdermal Medical Patch Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Novartis
  14. 8.3.1 Novartis Company Information
  15. 8.3.2 Novartis Business Overview
  16. 8.3.3 Novartis Transdermal Medical Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Novartis Transdermal Medical Patch Product Portfolio
  18. 8.3.5 Novartis Recent Developments
  19. 8.4 Mylan
  20. 8.4.1 Mylan Company Information
  21. 8.4.2 Mylan Business Overview
  22. 8.4.3 Mylan Transdermal Medical Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Mylan Transdermal Medical Patch Product Portfolio
  24. 8.4.5 Mylan Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Transdermal Medical Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Transdermal Medical Patch Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 GSK
  32. 8.6.1 GSK Company Information
  33. 8.6.2 GSK Business Overview
  34. 8.6.3 GSK Transdermal Medical Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 GSK Transdermal Medical Patch Product Portfolio
  36. 8.6.5 GSK Recent Developments
  37. 8.7 Beijing Tide Pharmaceutical
  38. 8.7.1 Beijing Tide Pharmaceutical Company Information
  39. 8.7.2 Beijing Tide Pharmaceutical Business Overview
  40. 8.7.3 Beijing Tide Pharmaceutical Transdermal Medical Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Beijing Tide Pharmaceutical Transdermal Medical Patch Product Portfolio
  42. 8.7.5 Beijing Tide Pharmaceutical Recent Developments
  43. 8.8 Bayer
  44. 8.8.1 Bayer Company Information
  45. 8.8.2 Bayer Business Overview
  46. 8.8.3 Bayer Transdermal Medical Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Bayer Transdermal Medical Patch Product Portfolio
  48. 8.8.5 Bayer Recent Developments
  49. 8.9 UCB Pharma
  50. 8.9.1 UCB Pharma Company Information
  51. 8.9.2 UCB Pharma Business Overview
  52. 8.9.3 UCB Pharma Transdermal Medical Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 UCB Pharma Transdermal Medical Patch Product Portfolio
  54. 8.9.5 UCB Pharma Recent Developments
  55. 8.10 Nitto Denko
  56. 8.10.1 Nitto Denko Company Information
  57. 8.10.2 Nitto Denko Business Overview
  58. 8.10.3 Nitto Denko Transdermal Medical Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Nitto Denko Transdermal Medical Patch Product Portfolio
  60. 8.10.5 Nitto Denko Recent Developments
  61. 8.11 Mundipharma
  62. 8.11.1 Mundipharma Company Information
  63. 8.11.2 Mundipharma Business Overview
  64. 8.11.3 Mundipharma Transdermal Medical Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Mundipharma Transdermal Medical Patch Product Portfolio
  66. 8.11.5 Mundipharma Recent Developments
  67. 8.12 Luye Pharma Group
  68. 8.12.1 Luye Pharma Group Company Information
  69. 8.12.2 Luye Pharma Group Business Overview
  70. 8.12.3 Luye Pharma Group Transdermal Medical Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Luye Pharma Group Transdermal Medical Patch Product Portfolio
  72. 8.12.5 Luye Pharma Group Recent Developments
  73. 8.13 IBSA Group
  74. 8.13.1 IBSA Group Company Information
  75. 8.13.2 IBSA Group Business Overview
  76. 8.13.3 IBSA Group Transdermal Medical Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 IBSA Group Transdermal Medical Patch Product Portfolio
  78. 8.13.5 IBSA Group Recent Developments
  79. 8.14 Hisamitsu Pharmaceutical
  80. 8.14.1 Hisamitsu Pharmaceutical Company Information
  81. 8.14.2 Hisamitsu Pharmaceutical Business Overview
  82. 8.14.3 Hisamitsu Pharmaceutical Transdermal Medical Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Hisamitsu Pharmaceutical Transdermal Medical Patch Product Portfolio
  84. 8.14.5 Hisamitsu Pharmaceutical Recent Developments
  85. 8.15 Grünenthal
  86. 8.15.1 Grünenthal Company Information
  87. 8.15.2 Grünenthal Business Overview
  88. 8.15.3 Grünenthal Transdermal Medical Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Grünenthal Transdermal Medical Patch Product Portfolio
  90. 8.15.5 Grünenthal Recent Developments
  91. 8.16 Endo International
  92. 8.16.1 Endo International Company Information
  93. 8.16.2 Endo International Business Overview
  94. 8.16.3 Endo International Transdermal Medical Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Endo International Transdermal Medical Patch Product Portfolio
  96. 8.16.5 Endo International Recent Developments
  97. 8.17 Dr Reddy’s Laboratories
  98. 8.17.1 Dr Reddy’s Laboratories Company Information
  99. 8.17.2 Dr Reddy’s Laboratories Business Overview
  100. 8.17.3 Dr Reddy’s Laboratories Transdermal Medical Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Dr Reddy’s Laboratories Transdermal Medical Patch Product Portfolio
  102. 8.17.5 Dr Reddy’s Laboratories Recent Developments
  103. 8.18 Chattem
  104. 8.18.1 Chattem Company Information
  105. 8.18.2 Chattem Business Overview
  106. 8.18.3 Chattem Transdermal Medical Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Chattem Transdermal Medical Patch Product Portfolio
  108. 8.18.5 Chattem Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Transdermal Medical Patch Value Chain Analysis
  2. 9.1.1 Transdermal Medical Patch Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Transdermal Medical Patch Production Mode & Process
  6. 9.2 Transdermal Medical Patch Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Transdermal Medical Patch Distributors
  9. 9.2.3 Transdermal Medical Patch Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst